UMIN-CTR History

Name：　　UMIN ID：


Unique ID issued by UMIN UMIN000011192
Receipt number R000012652
Scientific Title Hematopoietic stem cell transplantation from a related donor with HLA-1 Ag mismatch in the graft-versus-host direction using anti-thymocyte globulin as a GVHD prophylaxis: multicenter phase II trial.
Date of disclosure of the study information 2013/07/16
Last modified on 2020/12/31 11:06:45

No. Disposal Last modified on Item of update
1 Insert 2013/07/16 10:21:22
2 Update 2013/08/01 11:25:38 Recruitment status
3 Update 2013/11/06 09:51:10 Email
Name of person sending information
Name of person sending information
4 Update 2013/11/06 10:00:25 Key exclusion criteria
Key exclusion criteria
5 Update 2016/04/27 14:30:55 Organization
Organization
Division name
Division name
Address
Address
TEL
Email
Name of primary person or sponsor
Organization
6 Update 2016/04/27 14:31:17 Last follow-up date
7 Update 2017/07/05 13:49:50 Name of person sending information
Name of person sending information
Organization
Organization
Division name
Division name
Email
8 Update 2017/07/05 13:52:15 Recruitment status
Last follow-up date
9 Update 2017/07/05 15:08:14 UMIN ID1
10 Update 2017/07/05 15:10:08 Name of person sending information
Name of person sending information
Organization
Organization
Division name
Division name
Address
Address
TEL
Email
11 Update 2018/04/28 12:25:36 Date trial data considered complete
12 Update 2020/01/23 21:40:40 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code
Address

Last name of contact person

Last name of contact person
Division name
Division name
Zip code
Address
Division name
TEL
Organization
Organization
Address
Address
Tel
Email
13 Update 2020/01/23 21:44:30 Date of IRB
14 Update 2020/12/31 10:44:46 Recruitment status
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
15 Update 2020/12/31 11:06:45 URL releasing protocol
Publication of results
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results
Results date posted
Baseline Characteristics
Baseline Characteristics
Participant flow
Participant flow
Adverse events
Adverse events
Outcome measures
Outcome measures